15-Jan-2026
Samsara gets rating upgrade at BNP Paribas
Seeking Alpha News (Thu, 15-Jan 12:37 PM ET)
Veeva to Present at the J.P. Morgan 2026 Healthcare Conference
PRNewswire (Thu, 8-Jan 4:05 PM ET)
Veeva and BioMarin Form Long-Term Strategic Partnership
PRNewswire (Thu, 8-Jan 8:30 AM ET)
Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing
PRNewswire (Thu, 8-Jan 7:03 AM ET)
Novo Nordisk International Operations Commits to Veeva Vault CRM
PRNewswire (Wed, 7-Jan 7:03 AM ET)
Veeva’s First-Ever $2 Billion Share Repurchase Program Signals Confidence in Long-Term Growth
Market Chameleon (Tue, 6-Jan 4:24 AM ET)
Veeva Announces Share Repurchase Program
PRNewswire (Mon, 5-Jan 4:35 PM ET)
Veeva to Present at Upcoming Investor Conference
PRNewswire (Thu, 4-Dec 4:05 PM ET)
Veeva AI Agents Now Available to Increase Productivity and Customer Centricity
PRNewswire (Wed, 3-Dec 7:03 AM ET)
Veeva Announces Expanded Partnership with Roche
PRNewswire (Mon, 24-Nov 7:03 AM ET)
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Veeva Systems Class A trades on the NYSE stock market under the symbol VEEV.
As of January 15, 2026, VEEV stock price climbed to $218.95 with 2,541,642 million shares trading.
VEEV has a beta of 0.87, meaning it tends to be less sensitive to market movements. VEEV has a correlation of 0.17 to the broad based SPY ETF.
VEEV has a market cap of $35.99 billion. This is considered a Large Cap stock.
Last quarter Veeva Systems Class A reported $811 million in Revenue and $2.04 earnings per share. This beat revenue expectation by $19 million and exceeded earnings estimates by $.33.
In the last 3 years, VEEV traded as high as $310.50 and as low as $157.31.
The top ETF exchange traded funds that VEEV belongs to (by Net Assets): VTI, VO, VUG, VXF, VOT.
VEEV has underperformed the market in the last year with a price return of +3.8% while the SPY ETF gained +20.2%. VEEV has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -23.9% and -1.9%, respectively, while the SPY returned +4.8% and +1.5%, respectively.
VEEV support price is $214.68 and resistance is $223.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VEEV shares will trade within this expected range on the day.